CompletedNot Applicable

Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants

Turkey (Türkiye)70 participantsStarted 2009-01

Plain-language summary

To determine whether oral or intravenous ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosis in extremely-low-birth-weight preterm infants.

Who can participate

Age range1 Day – 7 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Birth weight below 1000 gram * Diagnosed patent ductus arteriosis by Echocardiographic examination Exclusion Criteria: * Accompanied other congenital cardiac anomalies * Severe thrombocytopenia \< 60.000 * Severe intracranial bleeding (Grade 3-4) * Intestinal abnormality and necrotising enterocolitis

What they're measuring

Efficacy and Safety of Oral Versus Intravenous Ibuprofen... ID: STO5336205575

Timeframe: 6 months

Trial details

NCT IDNCT01261117

SponsorZekai Tahir Burak Women's Health Research and Education Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-04

View on ClinicalTrials.gov More Patent Ductus Arteriosus trials